Nowadays, cancer immunotherapy includes approaches such as immuno-binding site-blocking therapy, adoptive immunotherapy, indoleamine 2, 3-dioxygenase 1 (IDO1) inhibitors, cancer vaccines, and nonspecific immunomodulators (180, 185, 186). Here, IDO1 is linked to cancer.